PD is clinically very heterogeneous, and LRRK2 G2019S is exemplary of this, manifesting as both early- and late-onset PD, and presents with a wide range of clinical symptoms which could be caused by diverse pathophysiological features. Here, LRRK2 is linked to Parkinson disease.